CHARACTERIZATION OF THE SUPERINDUCTION OF THE C-MYC PROTOONCOGENE IN FIBROBLASTS BY BENZAMIDE DERIVATIVES

被引:1
|
作者
DEVARAJ, PE
CLEMENS, MJ
JOHNSTONE, AP
机构
[1] ST GEORGE HOSP,SCH MED,DEPT CELLULAR & MOLEC SCI,DIV IMMUNOL,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND
[2] ST GEORGE HOSP,SCH MED,DEPT CELLULAR & MOLEC SCI,DIV BIOCHEM,LONDON SW17 0RE,ENGLAND
基金
英国惠康基金;
关键词
C-MYC PROTOONCOGENE; BENZAMIDES; SUPERINDUCTION; FIBROBLAST; POLY(ADP-RIBOSE) POLYMERASE;
D O I
10.1007/BF00929210
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In mouse fibroblasts stimulated from quiescence into proliferation by serum the induction of expression of the c-myc proto-oncogene is strongly stimulated by 3-methoxybenzamide. Similar superinduction effects are seen with related compounds such as 3-aminobenzamide and the acid analogues, 3-anisic acid and 3-aminobenzoic acid. Whereas the benzamide derivatives are inhibitors of poly(ADP-ribose) polymerase the acid analogues are not, suggesting that inhibition of this enzyme is not the basis for superinduction of the c-myc gene. Analysis of the kinetics of induction of c-myc mRNA indicates that the RNA accumulates more rapidly as well as to a higher level in the presence of serum plus 3-methoxybenzamide than with serum alone. However the stimulation is transient in both cases. Addition of actinomycin D at 30 min or 1 h after serum stimulation shows the c-myc mRNA to be stable at these times, in the presence or absence of 3-methoxybenzamide. Thus the effect of the latter on c-myc mRNA accumulation is likely to be exerted at the level of transcription or RNA processing rather than turnover of the mRNA.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [1] DIFFERENTIAL CONTROL OF PROTOONCOGENE C-MYC AND C-FOS EXPRESSION IN LYMPHOCYTES AND FIBROBLASTS
    MCNERNEY, R
    DARLING, D
    JOHNSTONE, A
    BIOCHEMICAL JOURNAL, 1987, 245 (02) : 605 - 608
  • [2] NEGATIVE AUTOREGULATION OF THE C-MYC PROTOONCOGENE
    KRETZNER, L
    KRUMM, A
    KRUSE, D
    GROUDINE, M
    EISENMAN, R
    FASEB JOURNAL, 1995, 9 (06): : A1327 - A1327
  • [3] REGULATION OF EXPRESSION OF THE C-MYC PROTOONCOGENE
    MARCU, KB
    BIOESSAYS, 1987, 6 (01) : 28 - 32
  • [4] The c-MYC Protooncogene Expression in Cholesteatoma
    Palko, Eniko
    Poliska, Szilard
    Csakanyi, Zsuzsanna
    Katona, Gabor
    Karosi, Tamas
    Helfferich, Frigyes
    Penyige, Andras
    Sziklai, Istvan
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] STRUCTURE OF THE QUAIL C-MYC PROTOONCOGENE AND ITS EXPRESSION IN NORMAL AND TRANSFORMED QUAIL FIBROBLASTS
    SCHEIDLER, S
    WODARZ, A
    SIEMEISTER, G
    BISTER, K
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (09): : 814 - 814
  • [6] C-MYC PROTOONCOGENE POLYPEPTIDE EXPRESSION IN ENDOMETRIOSIS
    SCHENKEN, RS
    JOHNSON, JV
    RIEHL, RM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (04) : 1031 - 1037
  • [7] MODULATION OF CELLULAR FUNCTIONS IN RETROORBITAL FIBROBLASTS USING ANTISENSE OLIGONUCLEOTIDES TARGETING THE C-MYC PROTOONCOGENE
    HEUFELDER, AE
    BAHN, RS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (07) : 1420 - 1432
  • [8] THE ROLE OF C-MYC PROTOONCOGENE IN CHRONIC MYELOGENOUS LEUKEMIA
    NIEBOROWSKASKORSKA, M
    RATAJCZAK, MZ
    CALABRETTA, B
    SKORSKI, T
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1994, 32 (04) : 231 - 234
  • [9] THE C-MYC PROTOONCOGENE - INVOLVEMENT IN CHROMOSOMAL-ABNORMALITIES
    RABBITTS, TH
    TRENDS IN GENETICS, 1985, 1 (12) : 327 - 331
  • [10] GENETIC ALTERATION OF THE C-MYC PROTOONCOGENE (MYC) IN HUMAN PRIMARY BREAST CARCINOMAS
    ESCOT, C
    THEILLET, C
    LIDEREAU, R
    SPYRATOS, F
    CHAMPEME, MH
    GEST, J
    CALLAHAN, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) : 4834 - 4838